I agree with you here Pete, with how entrenched Pfizer already is with everything that is going on, I just don't see how they wait longer than 12 months to make Leo an offer he (we)can't refuse.

Leo has said that the value of Cellceutix goes up exponentially as we advance through trials, and I think with the Kevetrin trials set to show so many secondary end points of efficacy, this will prove to big pharma that it works, and show the FDA that this must get a "breakthrough therapy" designation and straight advancement to Phase 3. If that happens then Pfizer will open the checkbook without hesitation and pay UP so they don't have to worry about competing with other big pharmas. That is my belief for a best case and likely scenario.